Report Overview
Musculoskeletal Disorders or MSDs are injuries anddisorders that affect the human body's movement ormusculoskeletal system (i.e. muscles, tendons, ligaments, nerves, discs, blood vessels, etc.). Common MSDs include: Carpal Tunnel Syndrome. Tendonitis. Muscle / Tendon
The global MSD Drugs market size was estimated at USD 82410 million in 2023 and is projected to reach USD 119340.92 million by 2032, exhibiting a CAGR of 4.20% during the forecast period.
North America MSD Drugs market size was estimated at USD 23047.63 million in 2023, at a CAGR of 3.60% during the forecast period of 2025 through 2032.
This report provides a deep insight into the global MSD Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global MSD Drugs Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the MSD Drugs market in any manner.
Global MSD Drugs Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
AbbVie
Amgen
Johnson & Johnson
Roche
Pfizer Inc
Eli Lilly
Merck
Novartis
UCB
Market Segmentation (by Type)
OTC
Rx Drugs
Market Segmentation (by Application)
Hospital
Retail Pharmacy
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the MSD Drugs Market
Overview of the regional outlook of the MSD Drugs Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of MSD Drugs
1.2 Key Market Segments
1.2.1 MSD Drugs Segment by Type
1.2.2 MSD Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 MSD Drugs Market Overview
2.1 Global Market Overview
2.1.1 Global MSD Drugs Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global MSD Drugs Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 MSD Drugs Market Competitive Landscape
3.1 Global MSD Drugs Sales by Manufacturers (2019-2025)
3.2 Global MSD Drugs Revenue Market Share by Manufacturers (2019-2025)
3.3 MSD Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global MSD Drugs Average Price by Manufacturers (2019-2025)
3.5 Manufacturers MSD Drugs Sales Sites, Area Served, Product Type
3.6 MSD Drugs Market Competitive Situation and Trends
3.6.1 MSD Drugs Market Concentration Rate
3.6.2 Global 5 and 10 Largest MSD Drugs Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 MSD Drugs Industry Chain Analysis
4.1 MSD Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of MSD Drugs Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 MSD Drugs Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global MSD Drugs Sales Market Share by Type (2019-2025)
6.3 Global MSD Drugs Market Size Market Share by Type (2019-2025)
6.4 Global MSD Drugs Price by Type (2019-2025)
7 MSD Drugs Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global MSD Drugs Market Sales by Application (2019-2025)
7.3 Global MSD Drugs Market Size (M USD) by Application (2019-2025)
7.4 Global MSD Drugs Sales Growth Rate by Application (2019-2025)
8 MSD Drugs Market Consumption by Region
8.1 Global MSD Drugs Sales by Region
8.1.1 Global MSD Drugs Sales by Region
8.1.2 Global MSD Drugs Sales Market Share by Region
8.2 North America
8.2.1 North America MSD Drugs Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe MSD Drugs Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific MSD Drugs Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America MSD Drugs Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa MSD Drugs Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 MSD Drugs Market Production by Region
9.1 Global Production of MSD Drugs by Region (2019-2025)
9.2 Global MSD Drugs Revenue Market Share by Region (2019-2025)
9.3 Global MSD Drugs Production, Revenue, Price and Gross Margin (2019-2025)
9.4 North America MSD Drugs Production
9.4.1 North America MSD Drugs Production Growth Rate (2019-2025)
9.4.2 North America MSD Drugs Production, Revenue, Price and Gross Margin (2019-2025)
9.5 Europe MSD Drugs Production
9.5.1 Europe MSD Drugs Production Growth Rate (2019-2025)
9.5.2 Europe MSD Drugs Production, Revenue, Price and Gross Margin (2019-2025)
9.6 Japan MSD Drugs Production (2019-2025)
9.6.1 Japan MSD Drugs Production Growth Rate (2019-2025)
9.6.2 Japan MSD Drugs Production, Revenue, Price and Gross Margin (2019-2025)
9.7 China MSD Drugs Production (2019-2025)
9.7.1 China MSD Drugs Production Growth Rate (2019-2025)
9.7.2 China MSD Drugs Production, Revenue, Price and Gross Margin (2019-2025)
10 Key Companies Profile
10.1 AbbVie
10.1.1 AbbVie MSD Drugs Basic Information
10.1.2 AbbVie MSD Drugs Product Overview
10.1.3 AbbVie MSD Drugs Product Market Performance
10.1.4 AbbVie Business Overview
10.1.5 AbbVie MSD Drugs SWOT Analysis
10.1.6 AbbVie Recent Developments
10.2 Amgen
10.2.1 Amgen MSD Drugs Basic Information
10.2.2 Amgen MSD Drugs Product Overview
10.2.3 Amgen MSD Drugs Product Market Performance
10.2.4 Amgen Business Overview
10.2.5 Amgen MSD Drugs SWOT Analysis
10.2.6 Amgen Recent Developments
10.3 Johnson and Johnson
10.3.1 Johnson and Johnson MSD Drugs Basic Information
10.3.2 Johnson and Johnson MSD Drugs Product Overview
10.3.3 Johnson and Johnson MSD Drugs Product Market Performance
10.3.4 Johnson and Johnson MSD Drugs SWOT Analysis
10.3.5 Johnson and Johnson Business Overview
10.3.6 Johnson and Johnson Recent Developments
10.4 Roche
10.4.1 Roche MSD Drugs Basic Information
10.4.2 Roche MSD Drugs Product Overview
10.4.3 Roche MSD Drugs Product Market Performance
10.4.4 Roche Business Overview
10.4.5 Roche Recent Developments
10.5 Pfizer Inc
10.5.1 Pfizer Inc MSD Drugs Basic Information
10.5.2 Pfizer Inc MSD Drugs Product Overview
10.5.3 Pfizer Inc MSD Drugs Product Market Performance
10.5.4 Pfizer Inc Business Overview
10.5.5 Pfizer Inc Recent Developments
10.6 Eli Lilly
10.6.1 Eli Lilly MSD Drugs Basic Information
10.6.2 Eli Lilly MSD Drugs Product Overview
10.6.3 Eli Lilly MSD Drugs Product Market Performance
10.6.4 Eli Lilly Business Overview
10.6.5 Eli Lilly Recent Developments
10.7 Merck
10.7.1 Merck MSD Drugs Basic Information
10.7.2 Merck MSD Drugs Product Overview
10.7.3 Merck MSD Drugs Product Market Performance
10.7.4 Merck Business Overview
10.7.5 Merck Recent Developments
10.8 Novartis
10.8.1 Novartis MSD Drugs Basic Information
10.8.2 Novartis MSD Drugs Product Overview
10.8.3 Novartis MSD Drugs Product Market Performance
10.8.4 Novartis Business Overview
10.8.5 Novartis Recent Developments
10.9 UCB
10.9.1 UCB MSD Drugs Basic Information
10.9.2 UCB MSD Drugs Product Overview
10.9.3 UCB MSD Drugs Product Market Performance
10.9.4 UCB Business Overview
10.9.5 UCB Recent Developments
11 MSD Drugs Market Forecast by Region
11.1 Global MSD Drugs Market Size Forecast
11.2 Global MSD Drugs Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe MSD Drugs Market Size Forecast by Country
11.2.3 Asia Pacific MSD Drugs Market Size Forecast by Region
11.2.4 South America MSD Drugs Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of MSD Drugs by Country
12 Forecast Market by Type and by Application (2025-2032)
12.1 Global MSD Drugs Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of MSD Drugs by Type (2025-2032)
12.1.2 Global MSD Drugs Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of MSD Drugs by Type (2025-2032)
12.2 Global MSD Drugs Market Forecast by Application (2025-2032)
12.2.1 Global MSD Drugs Sales (K MT) Forecast by Application
12.2.2 Global MSD Drugs Market Size (M USD) Forecast by Application (2025-2032)
13 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. MSD Drugs Market Size Comparison by Region (M USD)
Table 5. Global MSD Drugs Sales (K MT) by Manufacturers (2019-2025)
Table 6. Global MSD Drugs Sales Market Share by Manufacturers (2019-2025)
Table 7. Global MSD Drugs Revenue (M USD) by Manufacturers (2019-2025)
Table 8. Global MSD Drugs Revenue Share by Manufacturers (2019-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in MSD Drugs as of 2022)
Table 10. Global Market MSD Drugs Average Price (USD/MT) of Key Manufacturers (2019-2025)
Table 11. Manufacturers MSD Drugs Sales Sites and Area Served
Table 12. Manufacturers MSD Drugs Product Type
Table 13. Global MSD Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of MSD Drugs
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. MSD Drugs Market Challenges
Table 22. Global MSD Drugs Sales by Type (K MT)
Table 23. Global MSD Drugs Market Size by Type (M USD)
Table 24. Global MSD Drugs Sales (K MT) by Type (2019-2025)
Table 25. Global MSD Drugs Sales Market Share by Type (2019-2025)
Table 26. Global MSD Drugs Market Size (M USD) by Type (2019-2025)
Table 27. Global MSD Drugs Market Size Share by Type (2019-2025)
Table 28. Global MSD Drugs Price (USD/MT) by Type (2019-2025)
Table 29. Global MSD Drugs Sales (K MT) by Application
Table 30. Global MSD Drugs Market Size by Application
Table 31. Global MSD Drugs Sales by Application (2019-2025) & (K MT)
Table 32. Global MSD Drugs Sales Market Share by Application (2019-2025)
Table 33. Global MSD Drugs Sales by Application (2019-2025) & (M USD)
Table 34. Global MSD Drugs Market Share by Application (2019-2025)
Table 35. Global MSD Drugs Sales Growth Rate by Application (2019-2025)
Table 36. Global MSD Drugs Sales by Region (2019-2025) & (K MT)
Table 37. Global MSD Drugs Sales Market Share by Region (2019-2025)
Table 38. North America MSD Drugs Sales by Country (2019-2025) & (K MT)
Table 39. Europe MSD Drugs Sales by Country (2019-2025) & (K MT)
Table 40. Asia Pacific MSD Drugs Sales by Region (2019-2025) & (K MT)
Table 41. South America MSD Drugs Sales by Country (2019-2025) & (K MT)
Table 42. Middle East and Africa MSD Drugs Sales by Region (2019-2025) & (K MT)
Table 43. Global MSD Drugs Production (K MT) by Region (2019-2025)
Table 44. Global MSD Drugs Revenue (US$ Million) by Region (2019-2025)
Table 45. Global MSD Drugs Revenue Market Share by Region (2019-2025)
Table 46. Global MSD Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 47. North America MSD Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 48. Europe MSD Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 49. Japan MSD Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 50. China MSD Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 51. AbbVie MSD Drugs Basic Information
Table 52. AbbVie MSD Drugs Product Overview
Table 53. AbbVie MSD Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 54. AbbVie Business Overview
Table 55. AbbVie MSD Drugs SWOT Analysis
Table 56. AbbVie Recent Developments
Table 57. Amgen MSD Drugs Basic Information
Table 58. Amgen MSD Drugs Product Overview
Table 59. Amgen MSD Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 60. Amgen Business Overview
Table 61. Amgen MSD Drugs SWOT Analysis
Table 62. Amgen Recent Developments
Table 63. Johnson and Johnson MSD Drugs Basic Information
Table 64. Johnson and Johnson MSD Drugs Product Overview
Table 65. Johnson and Johnson MSD Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 66. Johnson and Johnson MSD Drugs SWOT Analysis
Table 67. Johnson and Johnson Business Overview
Table 68. Johnson and Johnson Recent Developments
Table 69. Roche MSD Drugs Basic Information
Table 70. Roche MSD Drugs Product Overview
Table 71. Roche MSD Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 72. Roche Business Overview
Table 73. Roche Recent Developments
Table 74. Pfizer Inc MSD Drugs Basic Information
Table 75. Pfizer Inc MSD Drugs Product Overview
Table 76. Pfizer Inc MSD Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 77. Pfizer Inc Business Overview
Table 78. Pfizer Inc Recent Developments
Table 79. Eli Lilly MSD Drugs Basic Information
Table 80. Eli Lilly MSD Drugs Product Overview
Table 81. Eli Lilly MSD Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 82. Eli Lilly Business Overview
Table 83. Eli Lilly Recent Developments
Table 84. Merck MSD Drugs Basic Information
Table 85. Merck MSD Drugs Product Overview
Table 86. Merck MSD Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 87. Merck Business Overview
Table 88. Merck Recent Developments
Table 89. Novartis MSD Drugs Basic Information
Table 90. Novartis MSD Drugs Product Overview
Table 91. Novartis MSD Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 92. Novartis Business Overview
Table 93. Novartis Recent Developments
Table 94. UCB MSD Drugs Basic Information
Table 95. UCB MSD Drugs Product Overview
Table 96. UCB MSD Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 97. UCB Business Overview
Table 98. UCB Recent Developments
Table 99. Global MSD Drugs Sales Forecast by Region (2025-2032) & (K MT)
Table 100. Global MSD Drugs Market Size Forecast by Region (2025-2032) & (M USD)
Table 101. North America MSD Drugs Sales Forecast by Country (2025-2032) & (K MT)
Table 102. North America MSD Drugs Market Size Forecast by Country (2025-2032) & (M USD)
Table 103. Europe MSD Drugs Sales Forecast by Country (2025-2032) & (K MT)
Table 104. Europe MSD Drugs Market Size Forecast by Country (2025-2032) & (M USD)
Table 105. Asia Pacific MSD Drugs Sales Forecast by Region (2025-2032) & (K MT)
Table 106. Asia Pacific MSD Drugs Market Size Forecast by Region (2025-2032) & (M USD)
Table 107. South America MSD Drugs Sales Forecast by Country (2025-2032) & (K MT)
Table 108. South America MSD Drugs Market Size Forecast by Country (2025-2032) & (M USD)
Table 109. Middle East and Africa MSD Drugs Consumption Forecast by Country (2025-2032) & (Units)
Table 110. Middle East and Africa MSD Drugs Market Size Forecast by Country (2025-2032) & (M USD)
Table 111. Global MSD Drugs Sales Forecast by Type (2025-2032) & (K MT)
Table 112. Global MSD Drugs Market Size Forecast by Type (2025-2032) & (M USD)
Table 113. Global MSD Drugs Price Forecast by Type (2025-2032) & (USD/MT)
Table 114. Global MSD Drugs Sales (K MT) Forecast by Application (2025-2032)
Table 115. Global MSD Drugs Market Size Forecast by Application (2025-2032) & (M USD)
List of Figures
Figure 1. Product Picture of MSD Drugs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global MSD Drugs Market Size (M USD), 2019-2032
Figure 5. Global MSD Drugs Market Size (M USD) (2019-2032)
Figure 6. Global MSD Drugs Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. MSD Drugs Market Size by Country (M USD)
Figure 11. MSD Drugs Sales Share by Manufacturers in 2023
Figure 12. Global MSD Drugs Revenue Share by Manufacturers in 2023
Figure 13. MSD Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market MSD Drugs Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by MSD Drugs Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global MSD Drugs Market Share by Type
Figure 18. Sales Market Share of MSD Drugs by Type (2019-2025)
Figure 19. Sales Market Share of MSD Drugs by Type in 2023
Figure 20. Market Size Share of MSD Drugs by Type (2019-2025)
Figure 21. Market Size Market Share of MSD Drugs by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global MSD Drugs Market Share by Application
Figure 24. Global MSD Drugs Sales Market Share by Application (2019-2025)
Figure 25. Global MSD Drugs Sales Market Share by Application in 2023
Figure 26. Global MSD Drugs Market Share by Application (2019-2025)
Figure 27. Global MSD Drugs Market Share by Application in 2023
Figure 28. Global MSD Drugs Sales Growth Rate by Application (2019-2025)
Figure 29. Global MSD Drugs Sales Market Share by Region (2019-2025)
Figure 30. North America MSD Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 31. North America MSD Drugs Sales Market Share by Country in 2023
Figure 32. U.S. MSD Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 33. Canada MSD Drugs Sales (K MT) and Growth Rate (2019-2025)
Figure 34. Mexico MSD Drugs Sales (Units) and Growth Rate (2019-2025)
Figure 35. Europe MSD Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 36. Europe MSD Drugs Sales Market Share by Country in 2023
Figure 37. Germany MSD Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 38. France MSD Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 39. U.K. MSD Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 40. Italy MSD Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 41. Russia MSD Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 42. Asia Pacific MSD Drugs Sales and Growth Rate (K MT)
Figure 43. Asia Pacific MSD Drugs Sales Market Share by Region in 2023
Figure 44. China MSD Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 45. Japan MSD Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 46. South Korea MSD Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 47. India MSD Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 48. Southeast Asia MSD Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 49. South America MSD Drugs Sales and Growth Rate (K MT)
Figure 50. South America MSD Drugs Sales Market Share by Country in 2023
Figure 51. Brazil MSD Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 52. Argentina MSD Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 53. Columbia MSD Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 54. Middle East and Africa MSD Drugs Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa MSD Drugs Sales Market Share by Region in 2023
Figure 56. Saudi Arabia MSD Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 57. UAE MSD Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 58. Egypt MSD Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 59. Nigeria MSD Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 60. South Africa MSD Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 61. Global MSD Drugs Production Market Share by Region (2019-2025)
Figure 62. North America MSD Drugs Production (K MT) Growth Rate (2019-2025)
Figure 63. Europe MSD Drugs Production (K MT) Growth Rate (2019-2025)
Figure 64. Japan MSD Drugs Production (K MT) Growth Rate (2019-2025)
Figure 65. China MSD Drugs Production (K MT) Growth Rate (2019-2025)
Figure 66. Global MSD Drugs Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global MSD Drugs Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global MSD Drugs Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global MSD Drugs Market Share Forecast by Type (2025-2032)
Figure 70. Global MSD Drugs Sales Forecast by Application (2025-2032)
Figure 71. Global MSD Drugs Market Share Forecast by Application (2025-2032)
